ROSS LONDON LIMITEDActive

Company number 04034409Private limited companyIncorporated 2000

Key figures

£86,850-12.0%
Net assets 2024/25
-11.8%
Average annual change 2019/20–2024/25
050 k100 k150 k200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ROSS LONDON LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets393,270359,161312,780263,693212,828
Total liabilities234,950216,302188,605155,200115,223
Net assets / total equity149,761134,852115,22098,63886,850
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ROSS LONDON LIMITED

Company

ROSS LONDON LIMITED is a private limited company registered with Companies House under company number 04034409. It was incorporated on 14 Jul 2000. Its status is active. The registered office is in London (E14). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460), non-specialised wholesale trade (46900), dispensing chemist in specialised stores (47730), other telecommunications activities (61900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £86,850, down 12% on the previous year. Total assets were £212,828 and total liabilities £115,223. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 30 Jun 2027.